Core Strategy - The company is focusing on its "big product" strategy, reallocating resources to core products that demonstrate strong market potential and clinical value [1][2] - Since the implementation of the "big product" strategy in 2020, the company has identified over 20 high-value traditional Chinese medicine products from nearly 200 options, categorized into various therapeutic series [1] Product Development - The company has selected five core products, including Jingzhi Niuhuang Jiedu Pian and Liuwei Dihuang Wan, and is implementing differentiated marketing strategies to enhance their market share [2] - The "Yuyao 300 Years" series is being positioned as a key component of marketing activities, aiming to strengthen market presence through partnerships with major retail chains [2] Market Expansion - The company plans to cultivate a range of small to medium-sized products that align with market demands, focusing on preventive health interventions [2] - In the non-pharmaceutical sector, the company aims to explore market potential for health products like Ejiao food series and Pi Pa Lu, leveraging existing sales channels for broader market reach [2]
同仁堂科技：聚焦！品种建设再升级